TipRanks
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
US Market
BLCO
Bausch + Lomb Corporation
RESEARCH TOOLSreports
Want to see BLCO full AI Analyst Report?

Bausch + Lomb Corporation (BLCO) Stock News & Sentiment

153 Followers
Bausch + Lomb Names Thomas Appio Interim CEO, Signals 2026 Guidance Raise
Premium
Company Announcements
Bausch + Lomb Names Thomas Appio Interim CEO, Signals 2026 Guidance Raise
17h ago
BLCO
Bausch + Lomb Prepares Oral Dry AMD Drug Candidate for Clinical Launch in 2027
Premium
Company Announcements
Bausch + Lomb Prepares Oral Dry AMD Drug Candidate for Clinical Launch in 2027
6d ago
BLCO
Bausch + Lomb Sets Date for Third-Quarter 2026 Earnings Release and Investor Call
Premium
Company Announcements
Bausch + Lomb Sets Date for Third-Quarter 2026 Earnings Release and Investor Call
8d ago
BLCO
Yi Chen Reiterates Buy on Bausch + Lomb, Citing Emerging Ophthalmology Pipeline and Maintaining $21 Price Target
Premium
Ratings
Yi Chen Reiterates Buy on Bausch + Lomb, Citing Emerging Ophthalmology Pipeline and Maintaining $21 Price Target
2M ago
BLCO
Bausch + Lomb Overhauls Board, Reaffirms 2026 Outlook
Premium
Company Announcements
Bausch + Lomb Overhauls Board, Reaffirms 2026 Outlook
2M ago
8K
BLCO
Bausch + Lomb Earnings Call Signals Growing Momentum
Premium
Company Announcements
Bausch + Lomb Earnings Call Signals Growing Momentum
2M ago
BLCO
Bausch + Lomb Shareholders Back Board and Executive Pay
Premium
Company Announcements
Bausch + Lomb Shareholders Back Board and Executive Pay
5M ago
8K
BLCO
More BLCO News >

BLCO News on the Web

Barclays Reaffirms Their Buy Rating on Bausch + Lomb Corporation (BLCO)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Thermo Fisher (TMO), Bausch + Lomb Corporation (BLCO) and DaVita (DVA)
TipRanks News
Bullish
Yi Chen Reiterates Buy on Bausch + Lomb, Citing Emerging Ophthalmology Pipeline and Maintaining $21 Price Target
TipRanks News
Bullish
Stifel Nicolaus Keeps Their Hold Rating on Bausch + Lomb Corporation (BLCO)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch + Lomb Corporation (BLCO) and Intellia Therapeutics (NTLA)
TipRanks News
Neutral
Bausch + Lomb (BLCO) Halts Development of Glaucoma Eye Drop After Phase 2 Study
GuruFocus News
Bearish
Bausch + Lomb says Phase 2 study of BL1107 did not achieve primary endpoint
TipRanks News
Bearish
Bausch + Lomb Falls Despite Bullish Citi Target Hike
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
BLCO
Sector Average
Media Buzz
This Week8 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BLCO’s Media Buzz Sentiment?
8 articles about BLCO were published this week. In an average week, 2.5 articles are published.
    What is BLCO’s weekly average amount of articles?
    In an average week, 2.5 articles about BLCO are published.
      What is BLCO’s News Sentiment?
      100% of articles about BLCO were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        IQVIQVIA Holdings
        GILDGilead Sciences
        ABBVAbbVie
        VRTXVertex Pharmaceuticals
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week